684 healthcare executives, clinicians and technology leaders rank vendors across 19 categories as buyers elevate interoperability, clinical continuity and implementation...
Submission includes a concurrent CLIA Waiver by Application for use of the test on the Co-Dx PCR Pro® instrument in...
Submission includes a concurrent CLIA Waiver by Application for use of the test on the Co-Dx PCR Pro® instrument in...
Validated clinical studies software measures 48 biomarkers and reduces study setup time by more than 90%NEW YORK, Aug. 4, 2026...
Multi-year research collaboration will focus initially on AML and MDS while advancing Electronic Genome Mapping for broader hematologic research applicationsPROVIDENCE,...
Five new customers in Q2 and 13 in the first half of 2026 — including expansion and multi-year agreements with...
For investor audiences and media only Second quarter 2026 total revenues decreased by 3% to US$90.2 million, compared to the...
Meetings in Shanghai and Changzhou link VitaGuard's commercial use in China with BioNexus' Southeast Asian plans and Fidelion's international licensing...
Upcoming AGC Biologics Manufacturing Facility in Yokohama, Japan This AGC Biologics site in Yokohama, Japan, as depicted in June 2026,...
New location expands access to advanced mental health treatments while serving as Greenbrook's flagship innovation center and blueprint for future...
Company targets a growing $1.2B+ North American pet oncology market leveraging proprietary exosome-based diagnostic technologies. ORLANDO, FL / ACCESS Newswire...
Transaction builds on argenx’s prior strategic investment in Forte Biosciences and reflects a disciplined approach to accessing novel biology that...
Strong second quarter performance with $1.5 billion in global product net sales, representing 60% year-over-year growth and 17% quarter-over-quarter growth...
Group sales were +6% at constant exchange rates (CER)1, -2% when reported in CHF and +8% in USD2, in the...
BETHLEHEM, Pa., July 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it will report its...
The #DearAI , powered by Microsoft, built and annotated by people with limb loss and limb differences, is now publicly...
The rapid test detects the Bundibugyo virus associated with the current outbreak and can support the diagnosis of both symptomatic...
Veteran Global Capital Markets Executive to Lead Institutional Finance, Strategic Investments and Global Project Funding as Tersis Accelerates International ExpansionBrooksville,...
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Frishantic today announced the launch of Frishantic Magnesium Glycinate, a chelated magnesium...
After a single intravitreal dose of 4D-150, visual acuity and anatomic control was maintained with consistent and durable treatment burden...